United States · FDA National Drug Code directory
Zavesca
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 66215-201_f9cb16ee-d325-b331-e053-6394a90ab08c
- Product NDC
- 66215-201
- Form
- CAPSULE
- Composition / generic term
- miglustat
- Labeler
- Actelion Pharmaceuticals US, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20030731
- Source listing expiry
- 20261231
Source-listed ingredients
- MIGLUSTAT — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 6 BLISTER PACK in 1 CARTON (66215-201-90) / 15 CAPSULE in 1 BLISTER PACK (66215-201-15) · 66215-201-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →